SEOM Clinical guidelines for the treatment of advanced colorectal cancer 2013

被引:0
作者
E. Casado-Saenz
J. Feliu
M. A. Gomez-España
A. Sanchez-Gastaldo
R. Garcia-Carbonero
机构
[1] Hospital Infanta Sofia,Medical Oncology Department
[2] Hospital La Paz,Medical Oncology Department
[3] Hospital Reina Sofia,Medical Oncology Department
[4] Hospital Universitario Virgen del Rocío,Servicio de Oncología Médica
[5] Instituto de Biomedicina de Sevilla (IBIS) [Universidad de Sevilla,undefined
[6] CSIC,undefined
[7] HUVR],undefined
来源
Clinical and Translational Oncology | 2013年 / 15卷
关键词
Colorectal cancer; Guidelines; Chemotherapy; Surgery;
D O I
暂无
中图分类号
学科分类号
摘要
Colorectal cancer (CRC) is the most common malignant tumor in Western countries. Despite efforts made to implement screening programmes for early detection and treatment, still half of the patients present or will eventually develop distant metastasis. Management of advanced CRC should be discussed within an experienced multidisciplinary team, to adequately select the most appropriate systemic therapeutic option, as well as the optimal way to integrate it with surgical procedures when indicated. Disease localization and extent, resectability of primary and metastatic disease, tumor biology and dynamics, clinical symptoms, personal preferences and patient’s ability to tolerate intensive chemotherapy or extensive surgical procedures are the key factors to properly design a customized treatment plan. The aim of the current manuscript is to provide synthetic practical guidelines regarding therapeutic options for advanced CRC.
引用
收藏
页码:996 / 1003
页数:7
相关论文
共 156 条
[21]  
Ellis LM(2004)Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 337-4713
[22]  
Ellis V(2010)Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer J Clin Oncol 28 4706-2048
[23]  
Pollock R(2007)Cetuximab for the treatment of colorectal cancer N Engl J Med. 357 2040-1664
[24]  
Broglio KR(2007)Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer J Clin Oncol 25 1658-312
[25]  
Nordlinger B(2013)CORRECT Study Group. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial Lancet 381 303-327
[26]  
Sorbye H(2013)Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: systematic review of all literature and meta-analysis of observational studies Cancer Treat Rev 39 321-undefined
[27]  
Glimelius B(undefined)undefined undefined undefined undefined-undefined
[28]  
Poston GJ(undefined)undefined undefined undefined undefined-undefined
[29]  
Schlag PM(undefined)undefined undefined undefined undefined-undefined
[30]  
Rougier P(undefined)undefined undefined undefined undefined-undefined